Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.
  • The Cook Central Office, 36 South Wabash Avenue, Chicago, will close 02/03/2025.  The new Cook Central Office will open at 115 South LaSalle, Chicago, for in-person service on 02/10/2025.  
  • ​UPDATE: The State Disbursement Unit (SDU) is processing all payments received. To verify the status of your payment, please log into the SDU parent portal or contact the SDU Customer Service Call Center at 877.225.7077.  For SDU business hours, click here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 24, 2010

Drug Name Review Type Class Manufacturer
Bepreve New Drug Initial Review Ophthalmic - Allergic Conjunctivitis Ista
Vivitrol New Drug Initial Review Opioid Antagonist Alkermes
Colcrys New Drug Initial Review Anti-Gout URL
Sabril New Drug Initial Review Anticonvulsant Lundbeck
Twynsta New Drug Initial Review Antihypertensive Combination Boehringer Ingelheim
Apriso New Drug Initial Review Ulcerative Colitis Salix
Besivance New Drug Appeal Ophthalmic Fluoroquinolone Bausch & Lomb
Ranexa New Drug Appeal Anti-Anginal Giliead
Vimpat New Drug Appeal Anticonvulsant UCB
Lamictal XR New Drug Appeal Anticonvulsant GlaxoSmithKline
Ulesfia New Drug Appeal Pediculocide Shionogi
Zenpep New Drug Appeal Pancreatic Enzyme Eurand
Xibrom PDL Appeal Ophthalmic � Anti-Inflammatory Ista
Istalol PDL Appeal Ophthalmic � Glaucoma Agent Ista